Gene-based pleiotropy across migraine with aura and migraine without aura patient groups
Zhao, Huiying, Eising, E., de Vries, B., Vijfhuizen, L.S., Anttila, V., Winsvold, B.S., Kurth, T., Stefansson, H., Kallela, M., Malik, R., Stam, A.H., Ikram, M.A., Ligthart, L., Freilinger, T., Alexander, M., Mu ller-Myhsok, B., Schreiber, S., Meitinger, T., Aromas, A., Eriksson, J.G., Boomsma, D.I., van Duijn, C.M., Zwart, J.-A., Quaye, L., Kubisch, C., Dichgans, M., Wessman, M., Stefansson, K., Chasman, D.I., Palotie, A., Martin, N.G., Montgomery, G.W., Ferrari, M.D., Terwindt, G.M., van den Maagdenberg, A.M.J.M., & Nyholt, Dale R. (2016) Gene-based pleiotropy across migraine with aura and migraine without aura patient groups. Cephalalgia, 36(7), pp. 648-657.
- It is unclear whether patients diagnosed according to International Classification of Headache Disorders criteria for migraine with aura (MA) and migraine without aura (MO) experience distinct disorders or whether their migraine subtypes are genetically related.
- Using a novel gene-based (statistical) approach, we aimed to identify individual genes and pathways associated both with MA and MO.
- Gene-based tests were performed using genome-wide association summary statistic results from the most recent International Headache Genetics Consortium study comparing 4505 MA cases with 34,813 controls and 4038 MO cases with 40,294 controls. After accounting for non-independence of gene-based test results, we examined the significance of the proportion of shared genes associated with MA and MO.
- We found a significant overlap in genes associated with MA and MO. Of the total 1514 genes with a nominally significant gene-based p value (pgene-based ≤ 0.05) in the MA subgroup, 107 also produced pgene-based ≤ 0.05 in the MO subgroup. The proportion of overlapping genes is almost double the empirically derived null expectation, producing significant evidence of gene-based overlap (pleiotropy) (pbinomial-test = 1.5 × 10–4). Combining results across MA and MO, six genes produced genome-wide significant gene-based p values. Four of these genes (TRPM8, UFL1, FHL5 and LRP1) were located in close proximity to previously reported genome-wide significant SNPs for migraine, while two genes, TARBP2 and NPFF separated by just 259 bp on chromosome 12q13.13, represent a novel risk locus. The genes overlapping in both migraine types were enriched for functions related to inflammation, the cardiovascular system and connective tissue.
- Our results provide novel insight into the likely genes and biological mechanisms that underlie both MA and MO, and when combined with previous data, highlight the neuropeptide FF-amide peptide encoding gene (NPFF) as a novel candidate risk gene for both types of migraine.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
Full-text downloads displays the total number of times this work’s files (e.g., a PDF) have been downloaded from QUT ePrints as well as the number of downloads in the previous 365 days. The count includes downloads for all files if a work has more than one.
|Item Type:||Journal Article|
|Keywords:||Migraine, aura, genome-wide, association, gene-based, pleiotropy|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2015 International Headache Society|
|Deposited On:||12 Jan 2016 01:41|
|Last Modified:||19 Feb 2017 12:11|
Repository Staff Only: item control page